NP30925 Psychiatry and Neurology Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 35.5 month (est.)
- Value
- £28M
- Sector
- HEALTH
- Published
- 18 Aug 2025
- Delivery
- To 02 Aug 2028 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
36 suppliers
- Accord Devon
- Aventis Pharma Reading
- Crescent Pharma Basingstoke
- CST Pharma Walsall
- Flynn Pharma Stevenage
- Glaxosmithkline Brentford
- Janssen Cilag High Wycombe
- Kent Pharmaceuticals Ashford
- Lupin Europe Knutsford
- Martindale Pharma Romford
- Mercury Pharmaceuticals London
- Necessity Supplies Northolt
- Novartis Pharmaceuticals London
- Pfizer Tadworth
- Sandoz Surrey
- Teva Castleford
- Wockhardt Wrexham
- Alturix Milton Keynes
- Consilient Health Richmond
- Focus Pharmaceuticals Burton upon Trent
- Galvany Pharma Stevenage
- Hikma Pharmaceuticals London
- Macure Pharma Aps København Nv
- MSN Labs Letchworth Garden City
- Neuraxpharm Berkshire
- Novumgen London
- Otsuka Pharmaceuticals Windsor
- Ranbaxy London
- Roche Products Welwyn Garden City
- Rovi Biotech Croydon
- Serb None
- Stada UK Thornton & Ross Huddersfield
- Zentiva Guildford
- Amarox Harrow
- Medical Valley Höllviken
- Lundbeck Watford
Description
Supply of psychiatry and neurology medicines to NHS Scotland.
Lot Division
1 | Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid Supply of carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier framework agreement per product line to seventeen (17) Framework Participants. |
2 | All other psychiatry and neurology medicines Supply of other psychiatry and neurology medicines to NHS Scotland. The Authority intends to award the Framework Agreement as a single supplier framework agreement per line to thirty-three (33). Framework Participants. |
Award Detail
1 | Accord (Devon)
|
2 | Aventis Pharma (Reading)
|
3 | Crescent Pharma (Basingstoke)
|
4 | CST Pharma (Walsall)
|
5 | Flynn Pharma (Stevenage)
|
6 | Glaxosmithkline (Brentford)
|
7 | Janssen Cilag (High Wycombe)
|
8 | Kent Pharmaceuticals (Ashford)
|
9 | Lupin Europe (Knutsford)
|
10 | Martindale Pharma (Romford)
|
11 | Mercury Pharmaceuticals (London)
|
12 | Necessity Supplies (Northolt)
|
13 | Novartis Pharmaceuticals (London)
|
14 | Pfizer (Tadworth)
|
15 | Sandoz (Surrey)
|
16 | Teva (Castleford)
|
17 | Wockhardt (Wrexham)
|
18 | Accord (Devon)
|
19 | Alturix (Milton Keynes)
|
20 | Consilient Health (Richmond)
|
21 | Crescent Pharma (Basingstoke)
|
22 | CST Pharma (Walsall)
|
23 | Flynn Pharma (Stevenage)
|
24 | Focus Pharmaceuticals (Burton upon Trent)
|
25 | Galvany Pharma (Stevenage)
|
26 | Glaxosmithkline (Brentford)
|
27 | Hikma Pharmaceuticals (London)
|
28 | Janssen Cilag (High Wycombe)
|
29 | Kent Pharmaceuticals (Ashford)
|
30 | Macure Pharma Aps (København Nv)
|
31 | Martindale Pharma (Romford)
|
32 | Mercury Pharmaceuticals (London)
|
33 | MSN Labs (Letchworth Garden City)
|
34 | Necessity Supplies (Northolt)
|
35 | Neuraxpharm (Berkshire)
|
36 | Novumgen (London)
|
37 | Otsuka Pharmaceuticals (Windsor)
|
38 | Pfizer (Tadworth)
|
39 | Ranbaxy (London)
|
40 | Roche Products (Welwyn Garden City)
|
41 | Rovi Biotech (Croydon)
|
42 | Sandoz (Surrey)
|
43 | Serb (None)
|
44 | Teva (Castleford)
|
45 | Stada UK Thornton & Ross (Huddersfield)
|
46 | Wockhardt (Wrexham)
|
47 | Zentiva (Guildford)
|
48 | Amarox (Harrow)
|
49 | Medical Valley (Höllviken)
|
50 | Lundbeck (Watford)
|
Award Criteria
Technical (Logistics) | 5.0 |
PRICE | 95.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) covers the thirty-six (36) month framework duration and the twelve (12) month extension period of the framework agreement. (SC Ref:805467)
Reference
- FTS 049343-2025